A. Lamarca et al.Design and validation of the GI-NEC score to prognosticate overall survival in patients with high-grade gastrointestinal neuroendocrine carcinomas

J Natl Cancer Inst

(2017)

S.P. Patel et al.A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART SWOG 1609) in patients with nonpancreatic neuroendocrine tumors

Clin Cancer Res

(2020)

There are more references available in the full text version of this article.